Not Yet RecruitingNot Applicable

Kinetics and Prognostic Value of NeuroFilament Light in Post-cardiac Arrest: A Prospective Multicenter Study

France270 participantsStarted 2026-09

Plain-language summary

The purpose of this study is to assess the prognostic value of absolute value and kinetic of neurofilament light chain (NFL) collected at different time points (at admission, 12h, 24h, 48h, 72h, 96h, and day 7 after ICU admission) in predicting poor and good neurological outcome in comatose patients after cardiac arrest.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients admitted to the ICU for cardiac arrest, * Patients who regained consciousness following in-hospital or out-of-hospital cardiac arrest, * Patients in a coma upon arrival in the ICU, defined by a Glasgow Coma Scale (GCS) score \<8, * Patients included in the AfterROSC2 cohort, Exclusion Criteria: * Terminally ill patients (death expected within 3 hours of admission to the ICU), * Minors, * Patients under legal guardianship, * Pregnant women, * Patients not enrolled in a social security program, * Prior inclusion in the CINEFIL study, * Restriction of active therapies prior to the first NFL biomarker assay, * Objection by a family member or trusted person, if present

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

modified Rankin Scale (mRS)

Timeframe: 3 months

Trial details

NCT IDNCT07760636

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-06

Contact for this trial

Sarah Benghanem, MD PhD

+ 00 33 1 58 41 43 3 sarah.benghanem@aphp.fr

View on ClinicalTrials.gov More Cardiac Arrest (CA) trials